The Retina Institute, L.L.C.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion

Not Applicable

Completed

Conditions: Macular Edema
Retinal Vein Occlusion

Interventions: Drug: Intravitreal injection of bevacizumab
Drug: Intravitreal injection of ranibizumab (0.5 mg per dose)

First Posted Date: 2011-09-05

Last Posted Date: 2017-10-27

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 150

Registration Number: NCT01428388

Locations: 🇺🇸
The Retina Institute, Saint Louis, Missouri, United States

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane

Not Applicable

Terminated

Conditions: Epiretinal Membrane
Macular Edema

Interventions: Drug: Dexamethasone Intravitreal Implant

First Posted Date: 2011-08-05

Last Posted Date: 2016-07-27

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 6

Registration Number: NCT01410201

Locations: 🇺🇸
The Retina Institute, St. Louis, Missouri, United States
🇺🇸
St. Lukes Hospital, Chesterfield, Missouri, United States
🇺🇸
St. Louis Eye Surgery and Laser Center, St. Louis, Missouri, United States

Anatomic Outcomes Following Ozurdex Injections

Completed

Conditions: Retinal Vein Occlusions

First Posted Date: 2011-01-25

Last Posted Date: 2016-07-27

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 10

Registration Number: NCT01282411

Locations: 🇺🇸
Barnes Retina Institute, St. Louis, Missouri, United States

Use of Spectral OCT in Combination Therapy

Completed

Conditions: Choroidal Neovascularization

First Posted Date: 2009-12-03

Last Posted Date: 2017-10-30

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 15

Registration Number: NCT01025063

Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations

Phase 2

Completed

Conditions: Retinal Vein Occlusion
Posterior Vitreous Detachment

Interventions: Drug: Ranibizumab

First Posted Date: 2009-01-28

Last Posted Date: 2017-10-30

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 32

Registration Number: NCT00831350

Locations: 🇺🇸
Barnes Retina Institute, Saint Louis, Missouri, United States

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

Phase 2

Conditions: Presumed Ocular Histoplasmosis (POHS)

Interventions: Drug: ranibizumab
Drug: verteporfin

First Posted Date: 2007-10-19

Last Posted Date: 2009-04-16

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 30

Registration Number: NCT00546936

Locations: 🇺🇸
Barnes Retina Institute, St. Louis, Missouri, United States
🇺🇸
Macula-Retina-Vitreous Service, Midwest Eye Institute, Indianapolis, Indiana, United States

Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma

Not Applicable

Conditions: Uveal Melanoma

First Posted Date: 2007-04-13

Last Posted Date: 2008-05-09

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 175

Registration Number: NCT00459849

Locations: 🇺🇸
Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Not Applicable

Conditions: Age-Related Macular Degeneration

Interventions: Drug: reduced fluence photodynamic therapy with Visudyne
Drug: Lucentis

First Posted Date: 2007-04-04

Last Posted Date: 2008-05-09

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 30

Registration Number: NCT00455871

Locations: 🇺🇸
Barnes Retina Institute, St. Louis, Missouri, United States

Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer

Not Applicable

Conditions: Elevated Intraocular Pressure

First Posted Date: 2006-12-11

Last Posted Date: 2008-05-09

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 300

Registration Number: NCT00409669

Locations: 🇺🇸
Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri, United States

Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls

Completed

Conditions: Nuclear Sclerotic Cataract

First Posted Date: 2006-12-04

Last Posted Date: 2016-07-27

Lead Sponsor: Barnes Retina Institute

Target Recruit Count: 49

Registration Number: NCT00406263

Locations: 🇺🇸
Barnes Retina Institute, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy